BioVinc Receives an SBIR Phase II Grant from the National Institutes of Health
BioVinc Receives an SBIR Phase II Grant from the National Institutes of Health BioVinc is pleased to announce that it has been awarded an SBIR Phase II grant from the National Institutes of Health (NIH/NIDCR). This grant will facilitate research and development towards the prevention/treatment of the very devastating dental affliction: osteonecrosis of the jaw…